Cargando…

Combining BET and HDAC inhibitors synergistically induces apoptosis of melanoma and suppresses AKT and YAP signaling

Histone acetylation marks have an important role in controlling gene expression and are removed by histone deacetylases (HDACs). These marks are read by bromodomain and extra-terminal (BET) proteins and novel inhibitiors of these proteins are currently in clinical development. Inhibitors of HDAC and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heinemann, Anja, Cullinane, Carleen, De Paoli-Iseppi, Ricardo, Wilmott, James S., Gunatilake, Dilini, Madore, Jason, Strbenac, Dario, Yang, Jean Y., Gowrishankar, Kavitha, Tiffen, Jessamy C., Prinjha, Rab K., Smithers, Nicholas, McArthur, Grant A., Hersey, Peter, Gallagher, Stuart J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673282/ https://www.ncbi.nlm.nih.gov/pubmed/26087189

Ejemplares similares

Targeting activating mutations of EZH2 leads to potent cell growth inhibition in human melanoma by derepression of tumor suppressor genes
por: Tiffen, Jessamy C., et al.
Publicado: (2015)

Inducible but Not Constitutive Expression of PD-L1 in Human Melanoma Cells Is Dependent on Activation of NF-κB
por: Gowrishankar, Kavitha, et al.
Publicado: (2015)

Histone Modifications, Modifiers and Readers in Melanoma Resistance to Targeted and Immune Therapy
por: Gallagher, Stuart J, et al.
Publicado: (2015)

Bromodomain inhibitor I‐BET151 suppresses immune responses during fungal–immune interaction
por: Domínguez‐Andrés, Jorge, et al.
Publicado: (2019)

Lysine Demethylases: Promising Drug Targets in Melanoma and Other Cancers
por: Punnia-Moorthy, Gaya, et al.
Publicado: (2021)

Sex bias of females in survival from cancer and infections. Is X the answer?
por: Emran, Abdullah Al, et al.
Publicado: (2021)

Inhibition of BET Proteins Reduces Right Ventricle Hypertrophy and Pulmonary Hypertension Resulting from Combined Hypoxia and Pulmonary Inflammation
por: Chabert, Clovis, et al.
Publicado: (2018)

Somatic Copy Number Amplification and Hyperactivating Somatic Mutations of EZH2 Correlate With DNA Methylation and Drive Epigenetic Silencing of Genes Involved in Tumor Suppression and Immune Responses in Melanoma
por: Tiffen, Jessamy, et al.
Publicado: (2016)

Autism-like syndrome is induced by pharmacological suppression of BET proteins in young mice
por: Sullivan, Josefa M., et al.
Publicado: (2015)

BET Inhibition Improves NASH and Liver Fibrosis
por: Middleton, Sarah A., et al.
Publicado: (2018)

Inhibition of Osteoclastogenesis and Inflammatory Bone Resorption by Targeting BET Proteins and Epigenetic Regulation
por: Park-Min, Kyung-Hyun, et al.
Publicado: (2014)

Nicotinamide Inhibits T Cell Exhaustion and Increases Differentiation of CD8 Effector T Cells
por: Alavi, Sara, et al.
Publicado: (2022)

Study of the Female Sex Survival Advantage in Melanoma—A Focus on X-Linked Epigenetic Regulators and Immune Responses in Two Cohorts
por: Emran, Abdullah Al, et al.
Publicado: (2020)

Targeting Epigenetic Regulators with HDAC and BET Inhibitors to Modulate Muscle Wasting
por: Nevi, Lorenzo, et al.
Publicado: (2023)

Do innate killing mechanisms activated by inflammasomes have a role in treating melanoma?
por: Emran, Abdullah Al, et al.
Publicado: (2020)

Induction of USP17 by combining BET and HDAC inhibitors in breast cancer cells
por: Borbely, Gabor, et al.
Publicado: (2015)

Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy
por: Manzotti, Gloria, et al.
Publicado: (2019)

Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
por: Song, Shumei, et al.
Publicado: (2020)

Marked Global DNA Hypomethylation Is Associated with Constitutive PD-L1 Expression in Melanoma
por: Chatterjee, Aniruddha, et al.
Publicado: (2018)

BET inhibitors repress expression of interferon-stimulated genes and synergize with HDAC inhibitors in glioblastoma
por: Gusyatiner, Olga, et al.
Publicado: (2021)

A BET Protein Inhibitor Targeting Mononuclear Myeloid Cells Affects Specific Inflammatory Mediators and Pathways in Crohn’s Disease
por: Elfiky, Ahmed M. I., et al.
Publicado: (2022)

Chromatin targeting drugs in cancer and immunity
por: Prinjha, Rab, et al.
Publicado: (2013)

Muscle hypertrophy in hypoxia with inflammation is controlled by bromodomain and extra-terminal domain proteins
por: Chabert, Clovis, et al.
Publicado: (2017)

Luciferase expression and bioluminescence does not affect tumor cell growth in vitro or in vivo
por: Tiffen, Jessamy C, et al.
Publicado: (2010)

Drawing on disorder: How viruses use histone mimicry to their advantage
por: Tarakhovsky, Alexander, et al.
Publicado: (2018)

N-terminal BET bromodomain inhibitors disrupt a BRD4-p65 interaction and reduce inducible nitric oxide synthase transcription in pancreatic β-cells
por: Nord, Joshua A., et al.
Publicado: (2022)

BET inhibition in advanced cutaneous T cell lymphoma is synergistically potentiated by BCL2 inhibition or HDAC inhibition
por: Kim, Sa Rang, et al.
Publicado: (2018)

To Bet or Not to Bet on T-bet As a Therapeutic Target in Emphysema?
por: Wang, Xiaoyun, et al.
Publicado: (2019)

Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines
por: Hölscher, Alexander S., et al.
Publicado: (2018)

Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies
por: Burmeister, Aaron, et al.
Publicado: (2022)

A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma
por: Kling, Matthew J., et al.
Publicado: (2022)

BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models
por: Wyce, Anastasia, et al.
Publicado: (2013)

Bromodomain Inhibitors Modulate FcγR-Mediated Mononuclear Phagocyte Activation and Chemotaxis
por: Banham, Gemma D., et al.
Publicado: (2022)

Sequential targeting of YAP1 and p21 enhances the elimination of senescent cells induced by the BET inhibitor JQ1
por: Zhang, Huan-Tian, et al.
Publicado: (2021)

SRGN crosstalks with YAP to maintain chemoresistance and stemness in breast cancer cells by modulating HDAC2 expression
por: Zhang, Zhijie, et al.
Publicado: (2020)

Combined targeted therapy and immunotherapy in the treatment of advanced melanoma
por: Wilmott, James S., et al.
Publicado: (2012)

Lifetime Prediction of Polymers: To Bet, or Not to Bet—Is This the Question?
por: Blanco, Ignazio
Publicado: (2018)

Brd2/4 and Myc regulate alternative cell lineage programmes during early osteoclast differentiation in vitro
por: Caputo, Valentina S., et al.
Publicado: (2020)

Galectin-3 expression is prognostic in diffuse type gastric adenocarcinoma, confers aggressive phenotype, and can be targeted by YAP1/BET inhibitors
por: Ajani, Jaffer A, et al.
Publicado: (2018)

Corrigendum: Isoform Age - Splice Isoform Profiling Using Long-Read Technologies
por: De Paoli-Iseppi, Ricardo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4lg9iil098bu4l0vtjvc3eck2o